• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Friday RX numbers out for Viekira Pak

@H3NPHLO: #Viekira: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 870 NRx@ 536. $ABBV
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 413. NRx@ 216. $ABBV

@H3NPHLO: #Harvoni: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 10,080 NRx@ 4,535. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 9,795. NRx@ 3,799. $GILD

@H3NPHLO: #Sovaldi: Prescr. figures for wk ending 4/3 (shrt wk) (Symphony/BBG) : TRx@ 2,060 NRx@ 868. $GILD
@H3NPHLO: @H3NPHLO IMS figures: TRx@ 1,916. NRx@ 700. $GILD

Follow on Twitter.

How do you accurately count Rx's?